Will Pfizer/BioNTech And Moderna Stay Atop The COVID-19 Vaccine Market Forever?

 
• By Alaric DeArment

BIO CEO panelist Rajeev Venkayya argued that the huge amount of investment in COVID-19 vaccines makes it possible for new players to challenge Comirnaty and Spikevax’s dominance.

• Source: Shutterstock

More from Anti-infective

More from Therapy Areas